Loading stock data…
GRDN
$41.83+1.32 (+3.26%)
Market ClosedLast close Jun 9
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Guardian Pharmacy Services, Inc. in the Healthcare sector is trading at $41.83. Wall Street consensus targets $43.17 (6 analysts), implying a +3.2% move over the next 12 months. The stock is currently near its 52-week high of $42.00, remaining 31.7% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$41.83
Potential Downside
0%
Whystock Fair Value$41.83
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
24.02%
Volume
Today's trading volume
260,437
Recent News
Guardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?
Guardian Pharmacy (GRDN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Statutory Profit Doesn't Reflect How Good Guardian Pharmacy Services' (NYSE:GRDN) Earnings Are
Investors were underwhelmed by the solid earnings posted by Guardian Pharmacy Services, Inc. ( NYSE:GRDN ) recently...
Guardian Pharmacy Services Q1 Earnings Call Highlights
Guardian Pharmacy Services (NYSE:GRDN) reported what executives described as a solid first quarter of 2026, with management saying the company successfully navigated the initial implementation of the Inflation Reduction Act’s new framework while maintaining its full-year revenue outlook and raising
The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Strong Q1 Beat And New Shelf Registration
In early May 2026, Guardian Pharmacy Services, Inc. reported first-quarter 2026 results showing sales of US$336.6 million and net income of US$13.3 million, up from US$329.31 million and US$9.45 million a year earlier, alongside a new shelf registration for its Class A common stock. The quarter also featured raised guidance, double-digit Adjusted EBITDA growth, and stronger resident and prescription volumes, as well as ESOP-linked equity offerings and director stock grants that modestly...
Guardian Pharmacy Services, Inc. Q1 2026 Earnings Call Summary
Moby summary of Guardian Pharmacy Services, Inc.'s Q1 2026 earnings call